Search Results
Optimizing Antiplatelet Therapy in Diabetes Mellitus | Dominick J. Angiolillo
How to Optimally Tailor Antiplatelet Therapy in Patients with NSTEMI: What have we learned?
ACC 2020: Update from the TWILIGHT Study — Prof Dominick J Angiolillo
Antiplatelet Therapy-Joseph M Sweeny, MD
Crushing It: In the setting of PCI for STEMI, Crushed Prasugrel Speeds Antiplatelet Effects
DAPT de-escalation options after bifurcation lesion 2-stent PCI/DES - Dr Dominick ANGIOLILLO
Considerations for Long-Term Antithrombotic Management – A Practical Approach, Dr. Dominick Angiolil
Entrevista a Dr. Dominick Angiolillo en el XVII Simposio Cardiopatía I - Cuidados A Cardiovasculares
ACES Coronary Series Ep 4 : Optimizing Potent Antiplatelet in Post PCI Patient
[TCTAP 2018] Wrap up Interview "NOACs in Atherosclerotic Cardiovascular Disease"
Inside JACC | Platelet Inhibitory Effects of Ticagrelor
TCTAP 2013 Wrap-up Interview "Antithrombotic Therapies"